HURRY UP AND WAIT AT FDA

HURRY UP AND WAIT AT FDA-biocentury: President Donald Trump has shown more interest in FDA than most recent presidents, prompting speculation in Washington that he plans to rapidly appoint an activist commissioner. Trump fueled the rumors when he told pharma CEOs on Jan. 31 that he had selected a “fantastic person” to lead the agency who would be named “fairly soon.”